DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CAMPTOSAR

« Back to Dashboard

Clinical Trials for Camptosar

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00004103	Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer	Completed	National Cancer Institute (NCI)	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well irinotecan and cisplatin followed by surgery, floxuridine, and cisplatin work in treating patients with stomach cancer.
NCT00004103	Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer	Completed	New York University School of Medicine	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with surgery may kill more tumor cells. PURPOSE: This phase II trial is studying how well irinotecan and cisplatin followed by surgery, floxuridine, and cisplatin work in treating patients with stomach cancer.
NCT00004182	Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer	Completed	National Cancer Institute (NCI)	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have metastatic or recurrent breast cancer.

Clinical Trial Conditions for Camptosar

Condition Name

Condition Name for Camptosar
Intervention	Trials
Colorectal Cancer	13
Gastric Cancer	8
Metastatic Colorectal Cancer	8

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Camptosar
Intervention	Trials
Colorectal Neoplasms	30
Adenocarcinoma	11
Glioma	10

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Camptosar

Trials by Country

Trials by Country for Camptosar
Location	Trials
United States	294
United Kingdom	20
Canada	13
Japan	8
Italy	7

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Camptosar
Location	Trials
California	22
Texas	22
Florida	19
Tennessee	17
North Carolina	17

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Camptosar

Clinical Trial Phase

Clinical Trial Phase for Camptosar
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	6
Phase 2	51

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Camptosar
Clinical Trial Phase	Trials
Completed	45
Recruiting	24
Terminated	17

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Camptosar

Sponsor Name

Sponsor Name for Camptosar
Sponsor	Trials
National Cancer Institute (NCI)	12
Genentech, Inc.	9
M.D. Anderson Cancer Center	9

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Camptosar
Sponsor	Trials
Other	84
Industry	78
NIH	13

Export unavailable in trial.
Subscribe for complete access.